About this policy
CMS NCA document | source_status=Closed | review_type=New | public_comment_open=False | document_id=CAG-00144N
Coverage indications
On August 1, 2007, we initiated the national coverage determination (NCD) process by opening a tracking sheet for Screening DNA Stool Test for Colorectal Cancer (CAG-00144N). CMS will not expand the colorectal cancer screening benefit to include coverage of this test because the FDA has determined that the only commercially available test, PreGen-Plus™, requires premarket review. We will consider a request for reconsideration when a commercially available stool DNA test has been cleared or approved by the FDA.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.